Data as of Sep 19
| -0.29 / -0.51%|
The 27 analysts offering 12-month price forecasts for Sanofi SA have a median target of 58.20, with a high estimate of 69.98 and a low estimate of 50.84. The median estimate represents a +2.67% increase from the last price of 56.69.
The current consensus among 30 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.